Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Dementia

Ambroxol Shows Promise in Slowing Parkinson’s Dementia

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes even saw cognitive gains, hinting at real disease-modifying power.

Avatar photo

Published

on

The devastating effects of dementia on individuals and their families have long been a major health challenge. Researchers at Lawson Research Institute are making groundbreaking strides by investigating whether Ambroxol, a commonly used cough medicine in Europe, can slow down dementia in people with Parkinson’s disease.

Published in the prestigious JAMA Neurology journal, this 12-month clinical trial involving 55 participants with Parkinson’s disease dementia (PDD) has provided promising results. The study, led by Cognitive Neurologist Dr. Stephen Pasternak, aimed to alter the course of Parkinson’s dementia and explore a new treatment avenue where few currently exist.

The clinical trial gave one group daily Ambroxol while the other received a placebo. Participants were monitored for memory loss, psychiatric symptoms, and GFAP, a blood marker linked to brain damage. The results indicate that Ambroxol may support brain function, especially in those genetically at risk of developing Parkinson’s disease dementia.

Ambroxol works by supporting the enzyme glucocerebrosidase (GCase), which is often low in individuals with Parkinson’s disease. This enzyme plays a crucial role in breaking down waste in brain cells, and when it doesn’t work properly, damage can occur. Dr. Pasternak learned about Ambroxol during his fellowship at The Hospital for Sick Children, where it was identified as a treatment for Gaucher disease – a rare genetic disorder caused by a deficiency of GCase.

The findings of this study are crucial because they suggest that Ambroxol may protect brain function in people with Parkinson’s-related diseases. This research is vital, especially since Parkinson’s dementia profoundly affects patients and families. If a drug like Ambroxol can help slow down its progression, it could offer real hope and improve lives.

Funded by the Weston Foundation, this study is an essential step toward developing new treatments for Parkinson’s disease and other cognitive disorders, including dementia with Lewy bodies. Dr. Pasternak and his team plan to start a follow-up clinical trial focused specifically on cognition later this year, further solidifying their commitment to finding effective solutions for individuals affected by these devastating diseases.

Alzheimer's

Uncovering the Hidden Defenses Against Alzheimer’s Disease: A Breakthrough Study on Brain Resilience

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through neural highways and how certain genes either accelerate its toxic journey or shield brain regions from damage. Their extended Network Diffusion Model pinpoints four gene categories that govern vulnerability or resilience, reshaping our view of Alzheimer’s progression and spotlighting fresh therapeutic targets.

Avatar photo

Published

on

Alzheimer’s disease is a complex condition that affects different parts of the brain in various ways. One key factor in the progression of the disease is the misbehavior of tau proteins, which can lead to toxic clumps forming inside neurons and impairing their function. Researchers have long sought to understand why some areas of the brain are more resilient to Alzheimer’s than others, a phenomenon known as selective vulnerability or resilience.

A recent study by researchers at the University of California, San Francisco (UCSF) has made significant strides in this area by combining advanced mathematical modeling with brain imaging and genetics. The study, published in Brain, identified multiple distinct pathways through which risk genes confer vulnerability or resilience to Alzheimer’s disease.

The researchers developed a model called the extended Network Diffusion Model (eNDM), which predicted where tau protein would spread next based on real-world brain connection data from healthy individuals. By applying this model to brain scans of 196 people at various stages of Alzheimer’s, they were able to identify areas that were resistant or vulnerable to the disease.

The study revealed four distinct types of genes: those that boost tau spread along the brain’s wiring (Network-Aligned Vulnerability), those that promote tau buildup in ways unrelated to connectivity (Network-Independent Vulnerability), those that help protect regions that are otherwise tau hotspots (Network-Aligned Resilience), and those that offer protection outside of the network’s usual path (Network-Independent Resilience).

These findings have significant implications for understanding Alzheimer’s disease and developing potential intervention targets. The study’s lead author, Ashish Raj, PhD, noted that their research offers a “hopeful map forward” in understanding and eventually stopping Alzheimer’s disease.

The researchers also highlighted the importance of considering the different biological functions of genes that respond independently of the network versus those that respond in concert with it. This nuanced approach could lead to more effective strategies for identifying potential intervention targets and developing treatments for Alzheimer’s disease.

Continue Reading

Dementia

“Decoding Alzheimer’s: 4 Hidden Patterns That Reveal a Risky Path”

UCLA scientists mined millions of electronic health records and uncovered four distinct “roadways” that funnel people toward Alzheimer’s—ranging from mental-health struggles to vascular troubles. Following these breadcrumb trails proved far better at predicting who will develop dementia than single risk factors. The findings hint that spotting—and halting—specific sequences early could rewrite how we prevent the disease.

Avatar photo

Published

on

The article you provided has some excellent points about how researchers at UCLA Health have made significant discoveries regarding Alzheimer’s disease. Here is a rewritten version of the text for better clarity and comprehension:

Alzheimer’s disease is often thought to strike randomly, but new research from UCLA Health reveals that there are four distinct pathways that lead to this condition. By analyzing electronic health records, scientists identified sequential diagnostic patterns that show how conditions progress step-by-step toward Alzheimer’s disease.

The study, published in the journal eBioMedicine, used data from nearly 25,000 patients in the University of California Health Data Warehouse and validated findings in the All of Us Research Program. Unlike previous research that focused on individual risk factors, this analysis mapped multi-step trajectories that can indicate greater risk factors for Alzheimer’s disease than single conditions.

“We found that understanding these pathways could fundamentally change how we approach early detection and prevention,” said first author Mingzhou Fu, a medical informatics pre-doctoral student at UCLA. “Recognizing sequential patterns rather than focusing on diagnoses in isolation may help clinicians improve Alzheimer’s disease diagnosis.”

The research identified four major trajectory clusters:

1. Hypertension often precedes depressive episodes, which then increase Alzheimer’s risk.
2. Other trajectories show different demographic and clinical characteristics, suggesting that different populations may be vulnerable to different progression routes.
3. Some patients exhibit consistent directional ordering, where conditions progress in a specific order, increasing the risk of Alzheimer’s disease.

When validated in an independent population, these multi-step trajectories predicted Alzheimer’s disease risk more accurately than single diagnoses alone. This finding suggests that healthcare providers could use trajectory patterns for early detection and prevention strategies.

The validation in the All of Us Research Program confirmed that these trajectory patterns apply across different populations and demographics. The team analyzed 5,762 patients who contributed 6,794 unique Alzheimer’s progression trajectories, using advanced computational methods to map temporal relationships between diagnoses leading to Alzheimer’s disease.

This groundbreaking research has significant implications for the field of neuroscience and could lead to more effective early detection and prevention strategies for Alzheimer’s disease.

Continue Reading

Chronic Illness

The Surprising Link Between Hearing Loss, Loneliness, and Lifespan

People who treat hearing loss with hearing aids or cochlear implants regain rich conversations, escape isolation, and may even protect their brains and lifespans—proof that better hearing translates into fuller living.

Avatar photo

Published

on

A groundbreaking new study has shed light on the surprising link between hearing loss, loneliness, and lifespan. Researchers from the USC Caruso Department of Otolaryngology – Head and Neck Surgery found that adults with hearing loss who used hearing aids or cochlear implants were more socially engaged and felt less isolated compared to those who didn’t use them.

The study, published in JAMA Otolaryngology – Head & Neck Surgery, is the first to link hearing aids and cochlear implants to improved social lives among adults with hearing loss. The researchers conducted a comprehensive review of 65 previously published studies, encompassing over five thousand participants, on how hearing aids and cochlear implants affect three key measures: social quality of life, perceived social handicap, and loneliness.

The findings suggest that hearing devices can help prevent the social disconnection and broader health consequences that can follow untreated hearing loss. When left unaddressed, hearing loss can make communication difficult, leading people to withdraw from conversations and social activities. This can lead to mental stimulation reduction, increased risk of loneliness, anxiety, depression, cognitive decline, and dementia.

The researchers found that adults using hearing devices feel more socially connected and less limited in social situations. They are better able to engage in group conversations and feel more at ease in noisy or challenging listening environments. Participants also reported feeling less socially handicapped by their hearing loss, with fewer barriers and frustrations during interactions and an improved ability to stay engaged without feeling excluded.

Those with cochlear implants reported the most improvement in their social quality of life, likely because cochlear implants offer greater hearing restoration than hearing aids, especially for individuals with more severe hearing loss. As a result, they may experience more noticeable improvements in social engagement once their hearing is restored.

While it was outside the scope of the study to measure how better social lives relate to improved cognitive outcomes, the researchers believe there may be a connection. Previous research has found managing hearing loss may be key to reducing the risk of cognitive decline and dementia. The study’s lead researcher, Janet Choi, MD, MPH, an otolaryngologist with Keck Medicine, believes that by restoring clearer communication, hearing devices may help preserve cognitive health by keeping the brain more actively involved and people more connected.

This research follows a January 2024 study by Choi showing that adults with hearing loss who use hearing aids have an almost 25% lower risk of mortality, suggesting that treating hearing loss can improve lifespan as well as social quality of life. These findings add to a growing body of research showing that hearing health is deeply connected to overall well-being.

Continue Reading

Trending